← Leaderboards
Cyril Y Bowers
Tulane University Of Louisiana
$138,875
Attributed
$138,875
Total exposure
15
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.6K · FY2005–06$100K$75K$50K$25K$0
'05
'06
Funding mix
By agency
NIH$138,875 · 15
By mechanism
M01$138,875 · 15
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Lu Qi$19,868,722
- Malwina Czarny-Ratajczak$4,838,693
- Hua Lu$18,463,532
- Gary B Baskin$798,496
- Yiping Chen$15,405,099
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectSomatotropinHormone TherapyGrowth Hormone Releasing HormoneHuman Therapy EvaluationClinical Trial Phase ICortisolSynthetic PeptideSecretionEndocrine PharmacologyAgingLeptinOsteocalcinAdrenal GlandsBody CompositionHuman Old Age (65+)Endocrine DisorderHuman Middle Age (35-64)EndocrinologyBlood LipoproteinBlood GlucoseGeriatricsCombination Chemotherapy
Grant awards (20)
CLINICAL & HORMONAL EFFECTS OF GHRP-2, GHRH AND GHRP-2+GHRH IN ELDERLY SUBJECTS$16,708
M01 · FY2006 · RR · contact PI
INVESTIGATION OF CLINICAL AND HORMONAL EFFECTS OF GHRP, GHRH, AND 1485 PLUS GHRH$1,943
M01 · FY2006 · RR · contact PI
CONSENT TO DRAW BLOOD FOR THE EVALUATION OF GHRELIN$1,554
M01 · FY2006 · RR · contact PI
EFFECT OF ACUTE ADMINISTRATION OF GHRELIN [60]$194
M01 · FY2006 · RR · contact PI
EFFECT OF ACUTE ADMINISTRATION OF GHRELIN [60]$49,253
M01 · FY2005 · RR
CLINICAL &HORMONAL EFFECTS OF GHRP-2, GHRH AND GHRP-2+GHRH IN ELDERLY SUBJECTS$2,366
M01 · FY2005 · RR
Effect of Acute Administration of Ghrelin [60]$5,125
M01 · FY2004 · RR
Clinical &Hormonal Effects of GHRP-2, GHRH and GHRP-2+GHRH in Elderly Subjects$3,888
M01 · FY2004 · RR
Consent to Draw Blood for the Evaluation of Ghrelin$1,944
M01 · FY2004 · RR
CLINICAL/HORMONAL EFFECTS OF GHRP-1 INFUSION$0
M01 · FY2001 · RR
CLINICAL AND HORMONE EFFECTS OF GHRP-2, GHRH AND GHRP-2 + GHRH IN ELDERLY$0
M01 · FY2001 · RR
CLINICAL &HORMONAL EFFECTS OF GHRP 2 ADMINISTERED BY INFUSION FOR 30$0
M01 · FY2001 · RR
GHRP-2 AND GHRH IN THE ELDERLY$0
M01 · FY2001 · RR
CLINICAL &HORMONAL EFFECTS OF GHRP 2 ADMINISTERED BY INFUSION FOR 30$11,180
M01 · FY2000 · RR
CLINICAL AND HORMONE EFFECTS OF GHRP-2, GHRH AND GHRP-2 + GHRH IN ELDERLY$11,180
M01 · FY2000 · RR
CLINICAL/HORMONAL EFFECTS OF GHRP-2 IN ARTHRITIS/LUPUS/FIBROMYALGIA$11,180
M01 · FY2000 · RR
STUDY OF CLINICAL/HORMONAL EFFECTS OF GHRP-2 AND GHRH-2+GHRH IN THE ELDERLY$11,180
M01 · FY2000 · RR
CLINICAL/HORMONAL EFFECTS OF GROWTH HORMONE RELEASING PEPTIDE (GHRP-2) SUBCUT$11,180
M01 · FY2000 · RR
CLINICAL/HORMONAL EFFECTS OF GHRP-1 INFUSION$0
M01 · FY2000 · RR
GHRP-2 AND GHRH IN THE ELDERLY$0
M01 · FY2000 · RR